84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]吳曉颯,李春峰,劉巍,等.浮針療法聯(lián)合推髕手法治療髕骨軟化癥的臨床研究[J].中醫(yī)正骨,2025,37(01):51-57.
　WU Xiaosa,LI Chunfeng,LIU Wei,et al.A clinical study of fu's acupuncture therapy combined with patella-pushing manipulation for treatment of chondromalacia patellae[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2025,37(01):51-57.
點擊復制

浮針療法聯(lián)合推髕手法治療髕骨軟化癥的臨床研究()
分享到：

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第37卷
期數(shù):
2025年01期
頁碼:
51-57
欄目:
臨床研究
出版日期:
2025-01-20

文章信息/Info

Title:
A clinical study of fu's acupuncture therapy combined with patella-pushing manipulation for treatment of chondromalacia patellae
作者:
吳曉颯1; 李春峰2; 劉巍2; 龍大偉2; 吳新州2
1.安徽中醫(yī)藥大學第一臨床醫(yī)學院,安徽 合肥 230031; 2.太和縣中醫(yī)院,安徽 太和 236607
Author(s):
WU Xiaosa1; LI Chunfeng2; LIU Wei2; LONG Dawei2; WU Xinzhou2
1.The First Clinical Medical College of Anhui University of Chinese Medicine,Hefei 230031,Anhui,China 2.Taihe Hospital of Traditional Chinese Medicine,Taihe 236607,Anhui,China
關鍵詞:
髕骨軟骨軟化;  浮針療法;  推拿療法
Keywords:
chondromalacia patellae;  Fu's acupuncture therapy;  Tui Na therapy
摘要:
目的:探討浮針療法聯(lián)合推髕手法治療髕骨軟化癥的臨床療效和安全性。方法:將96例髕骨軟化癥患者隨機分為浮針聯(lián)合手法組、浮針組、手法組和口服西藥組,每組24例,分別采用浮針療法聯(lián)合推髕手法、浮針療法、推髕手法、口服鹽酸氨基葡萄糖片治療。浮針療法每隔2 d治療1次,推髕手法每日早晚各治療1次,口服鹽酸氨基葡萄糖片每日2次,均連續(xù)治療14 d。分別于治療前和治療結束后,采用Lysholm膝關節(jié)評分評價膝關節(jié)功能,采用Kujala髕股關節(jié)評分評價髕股關節(jié)功能和癥狀嚴重程度,采用視覺模擬量表(visual analogue scale,VAS)評分評價膝部疼痛程度。治療結束后3個月,按照《中醫(yī)病證診斷療效標準》中髕骨軟化癥療效評定標準評價綜合療效。治療及隨訪過程中觀察患者的不良反應發(fā)生情況。結果:①Lysholm膝關節(jié)評分。治療結束后,4組患者的Lysholm膝關節(jié)評分均較治療前增高(t=18.620,P=0.000; t=7.378,P=0.000; t=12.658,P=0.000; t=11.028,P=0.000)。浮針聯(lián)合手法組的Lysholm膝關節(jié)評分高于浮針組、手法組、口服西藥組(P=0.000,P=0.000,P=0.000)。浮針組、手法組、口服西藥組的Lysholm膝關節(jié)評分比較,組間差異均無統(tǒng)計學意義(P=0.210,P=0.793,P=0.187)。②Kujala髕股關節(jié)評分。治療結束后,4組患者的Kujala髕股關節(jié)評分均較治療前增高(t=10.883,P=0.000; t=13.091,P=0.000; t=13.038,P=0.000; t=11.412,P=0.000)。浮針聯(lián)合手法組的Kujala髕股關節(jié)評分高于浮針組、手法組、口服西藥組(P=0.000,P=0.000,P=0.000)。浮針組、手法組、口服西藥組的Kujala髕股關節(jié)評分比較,組間差異均無統(tǒng)計學意義(P=0.547,P=0.320,P=0.096)。③膝部疼痛VAS評分。治療結束后,4組患者的膝部疼痛VAS評分均較治療前降低(t=7.245,P=0.000; t=3.675,P=0.001; t=5.150,P=0.000; t=3.129,P=0.003)。浮針聯(lián)合手法組的膝部疼痛VAS評分低于浮針組、口服西藥組(P=0.022,P=0.001),與手法組比較差異無統(tǒng)計學意義(P=0.164)。浮針組、手法組、口服西藥組的膝部疼痛VAS評分比較,組間差異均無統(tǒng)計學意義(P=0.441,P=0.241,P=0.061)。④綜合療效。治療結束后3個月,4組患者的綜合療效比較,差異無統(tǒng)計學意義(χ2=5.935,P=0.115)。⑤安全性。4組患者中,浮針聯(lián)合手法組和浮針組各有1例患者在治療過程中出現(xiàn)暈針現(xiàn)象,其他患者在整個治療過程中均未出現(xiàn)不良反應。4組患者不良反應發(fā)生率比較,差異無統(tǒng)計學意義(P=1.000)。結論:浮針療法聯(lián)合推髕手法與單獨使用浮針療法、推髕手法和口服鹽酸氨基葡萄糖片治療髕骨軟化癥,均可緩解膝部疼痛、減輕髕股關節(jié)癥狀和改善膝關節(jié)功能; 其中浮針療法聯(lián)合推髕手法在緩解膝部疼痛方面的療效優(yōu)于單獨使用浮針療法和口服鹽酸氨基葡萄糖片,與單獨使用推髕手法相當,且該療法在減輕髕股關節(jié)癥狀和改善膝關節(jié)功能方面的療效優(yōu)于其他3種療法,但是這4種療法的綜合療效和安全性相當。
Abstract:
Objective:To explore the clinical outcomes and safety of fu's acupuncture therapy combined with patella-pushing manipulation for treatment of chondromalacia patellae(CMP).Methods:Ninety-six CMP patients were randomized into 4 groups,with 24 ones in each group,and they were treated with fu's acupuncture therapy combined with patella-pushing manipulation(combination therapy group),fu's acupuncture therapy(fu's acupuncture group),patella-pushing manipulation(manipulation group),and oral application of glucosamine hydrochloride tablets(western medicine(WM)group),respectively.The fu's acupuncture therapy was performed once every 2 days for consecutive 14 days; the patella-pushing manipulation was conducted once in the morning and evening,respectively,for consecutive 14 days; and the glucosamine hydrochloride tablets was taken twice a day,1 tablet at a time for consecutive 14 days.Before the treatment and after the end of the treatment,the knee function was assessed by using the Lysholm knee score,the patellofemoral function and the severity of the symptoms were evaluated by employing the Kujala patellofemoral score,and the knee pain degree was evaluated by using the visual analogue scale(VAS)score.Three months after the end of treatment,the total clinical outcomes were evaluated according to the therapeutic effect evaluation standard of CMP which was extracted from Standard for diagnosis and therapeutic effectiveness evaluation of traditional Chinese medicine syndromes,and the adverse reactions were observed during the treatment and follow-up period.Results:①The Lysholm knee score.The Lysholm knee score increased after the end of the treatment compared to pretreatment in the 4 groups(t=18.620,P=0.000; t=7.378,P=0.000; t=12.658,P=0.000; t=11.028,P=0.000),and it was higher in combination therapy group compared to fu's acupuncture group,manipulation group,and WM group(P=0.000,P=0.000,P=0.000),while,there was no significant difference among fu's acupuncture group,manipulation group,and WM group(P=0.210,P=0.793,P=0.187).②The Kujala patellofemoral score.The Kujala patellofemoral score increased after the end of the treatment compared to pretreatment in the 4 groups(t=10.883,P=0.000; t=13.091,P=0.000; t=13.038,P=0.000; t=11.412,P=0.000),and it was higher in combination therapy group compared to fu's acupuncture group,manipulation group,and WM group(P=0.000,P=0.000,P=0.000),while,there was no significant difference among fu's acupuncture group,manipulation group,and WM group(P=0.547,P=0.320,P=0.096).③The knee pain VAS score.The knee pain VAS score decreased after the end of the treatment compared to pretreatment in the 4 groups(t=7.245,P=0.000; t=3.675,P=0.001; t=5.150,P=0.000; t=3.129,P=0.003),and it was lower in combination therapy group compared to fu's acupuncture group and WM group(P=0.022,P=0.001),while there was no significant difference between combination therapy group and manipulation group(P=0.164); furthermore,the differences were not significant among fu's acupuncture group,manipulation group,and WM group(P=0.441,P=0.241,P=0.061).④The total clinical outcomes.Three months after the end of treatment,the difference was not significant in the total clinical outcomes among the 4 groups(χ2=5.935,P=0.115).⑤The safety.Among the 4 groups,1 patient each in the combination therapy group and fu's acupuncture group experienced fainting during the acupuncture treatment process,apart from that,no adverse reactions occurred in the other patients throughout the entire treatment.There was no statistical difference in the incidence of adverse reactions among the 4 groups(P=1.000).Conclusion:Combination of fu's acupuncture therapy with patella-pushing manipulation,or exclusive use of fu's acupuncture therapy,patella-pushing manipulation,and oral application of glucosamine hydrochloride tablets all can relieve knee pain,alleviate patellofemoral symptoms and improve knee function in the treatment of CMP.Among the 4 therapies,the fu's acupuncture therapy combined with patella-pushing manipulation is superior to fu's acupuncture therapy or oral application of glucosamine hydrochloride tablets alone,but,comparable to patella-pushing manipulation alone in alleviating knee pain,while,it outperformes the other 3 therapies in alleviating patellofemoral symptoms and improving knee function.However,the 4 therapies are similar to each other in the total clinical outcomes and safety in treatment of CMP.

參考文獻/References:

[1] KIZILGÖZ V,KANTARCI M,AYDIN S.Association between the subcutaneous fat thickness of the knee and chondromalacia patella:a magnetic resonance imaging-based study[J].J Int Med Res,2023,51(6):3000605231183581.
[2] TABARY M,ESFAHANI A,NOURAIE M,et al.Relation of the chondromalatia patellae to proximal tibial anatomical parameters,assessed with MRI[J].Radiol Oncol,2020,54(2):159-167.
[3] SIRIK M,ULUDAG A.Assessment of the relationship between patellar volume and chondromalacia patellae using knee magnetic resonance imaging[J].North Clin Istanb,2019,7(3):280-283.
[4] 陳建平,陳楠,譚惠森,等.浮針聯(lián)合鹽酸羥考酮緩釋片治療對中、重度癌痛患者炎癥因子和疼痛的影響[J].現(xiàn)代醫(yī)學與健康研究電子雜志,2024,8(18):117-119.
[5] 中華中醫(yī)藥學會.髕骨軟骨軟化癥[J].風濕病與關節(jié)炎,2013,2(1):78-80.
[6] CHIU P E,FU Z,SUN J,et al.Fu's subcutaneous needling for knee osteoarthritis pain[J].J Vis Exp,2023(193):1-17.
[7] COLLINS N J,MISRA D,FELSON D T,et al.Measures of knee function:International Knee Documentation Committee(IKDC)subjective knee evaluation form,knee injury and osteoarthritis outcome score(KOOS),knee injury and osteoarthritis outcome score physical function short form(KOOS-PS),Knee outcome survey activities of daily living scale(KOS-ADL),Lysholm knee scoring scale,Oxford knee score(OKS),Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC),activity rating scale(ARS),and Tegner activity score(TAS)[J].Arthritis Care Res(Hoboken),2011,63(Suppl 11):S208-S228.
[8] CHEUNG R T,NGAI S P,LAM P L,et al.Chinese translation and validation of the Kujala scale for patients with patellofemoral pain[J].Disabil Rehabil,2012,34(6):510-513.
[9] 嚴廣斌.視覺模擬評分法[J].中華關節(jié)外科雜志(電子版),2014,8(2):34.
[10] 國家中醫(yī)藥管理局.中醫(yī)病證診斷療效標準[M].南京:南京大學出版社,1994:198.
[11] 黃桂成,王擁軍.中醫(yī)骨傷科學[M].4版.北京:中國中醫(yī)藥出版社,2016:269-270.
[12] V S,R A,HARAN H,et al.Enhanced bone marrow aspirate concentrate(BMAC)preparation strategy in the management of chondromalacia patella:a case report[J].Cureus,2024,16(4):e59321.
[13] 方雨婷,柳直.髕骨軟化導致髕股關節(jié)炎病因機制及治療的研究進展[J].甘肅科技,2022,38(17):102-104.
[14] ÖZTÜRK C,GÜNGÖR Ö.Relationship between patellofemoral joint morphology and chondromalacia patella[J].Acta Radiol,2024,65(1):62-67.
[15] ATAY M.Relationship between trochlear dysplasia and chondromalacia patellae[J].Bagcilar Med Bull,2023,8(1):53-56.
[16] 宗毅,袁羚鐘.浮針配合再灌注活動治療落枕的療效觀察[J].中國中醫(yī)急癥,2024,33(1):142-144.
[17] MYERS T W.解剖列車:徒手與動作治療的肌筋膜經線[M].關玲,周維金,翁長水,譯.3版.北京:軍事醫(yī)學科學出版社,2015:109-150.
[18] 符仲華.肌肉學概要:基于浮針診療實踐的探索[M].北京:人民衛(wèi)生出版社,2023:247-248.
[19] 李虎,白田雨,孫健,等.浮針醫(yī)學患肌理論臨床應用舉隅[J].山東中醫(yī)雜志,2021,40(3):311-314.
[20] 郭富明,劉付懿斐,楊俊興.浮針聯(lián)合體外沖擊波治療髕骨軟化癥的療效觀察[J].上海針灸雜志,2022,41(9):912-917.
[21] 李峰,張云飛,文永兵,等.浮針聯(lián)合平樂正骨手法治療髕股關節(jié)疼痛綜合征的研究[J].中醫(yī)研究,2024,37(1):62-65.
[22] 寇龍威,郭珈宜,郭艷幸,等.針藥結合治療髕骨軟化癥臨床研究[J].中醫(yī)藥臨床雜志,2021,33(3):560-564.
[23] CAI Y,DENG Y,OU L,et al.Clinical trial of manual therapy in the treatment of chondromalacia patellae[J].Medicine(Baltimore),2023,102(24):e33945.
[24] SANCHIS-ALFONSO V.圖解髕股關節(jié)病[M].孫鐵錚,譯.北京:北京大學醫(yī)學出版社,2021:16-18.
[25] 董偉,姜曉麗,谷源林,等.浮針聯(lián)合富血小板血漿治療膝骨性關節(jié)炎[J].吉林中醫(yī)藥,2023,43(12):1480-1483.
[26] 鄧業(yè)川,趙敏明.溫針灸、浮針及針刺治療膝骨性關節(jié)炎臨床研究[J].陜西中醫(yī),2020,41(10):1496-1499.
[27] 程慧,鄭偉,張暑嵐,等.浮針療法聯(lián)合口服消髓化核湯治療腰椎間盤突出癥的臨床研究[J].中醫(yī)正骨,2024,36(7):17-21.

相似文獻/References:

[1]楊樹明,潘賜明,丁家雯.髕骨軟化癥中醫(yī)證型分布規(guī)律及危險因素分析[J].中醫(yī)正骨,2024,36(06):32.
　YANG Shuming,PAN Ciming,DING Jiawen.Analysis of distribution rules and risk factors for traditional Chinese medicine syndrome types in patients with chondromalacia patellae[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2024,36(01):32.
[2]程慧,鄭偉,張暑嵐,等.浮針療法聯(lián)合口服消髓化核湯治療腰椎間盤突出癥的臨床研究[J].中醫(yī)正骨,2024,36(07):17.
　CHENG Hui,ZHENG Wei,ZHANG Shulan,et al.A clinical study of floating acupuncture therapy combined with oral application of Xiaosui Huahe Tang(消髓化核湯)for treatment of lumbar disc herniation[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2024,36(01):17.
[3]危欣玲,盧俊樾,虞燕,等.浮針治療慢性肌骨疼痛的研究進展[J].中醫(yī)正骨,2024,36(10):61.
[4]王玉文,朱民順,梁龍,等.浮針療法聯(lián)合塞來昔布膠囊口服治療早中期膝骨關節(jié)炎[J].中醫(yī)正骨,2025,37(01):76.

備注/Memo

備注/Memo:
基金項目:安徽中醫(yī)藥大學科研基金項目(2023LCTH25)
通訊作者:李春峰 E-mail:[email protected]
更新日期/Last Update: 1900-01-01